Jamie Wood, MD, discusses the impact of Afrezza’s recent FDA approval for pediatric patients with type 1 and type 2 diabetes.
Jamie Wood, MD
Advertisement
Jamie Wood, MD, is the medical director of pediatric diabetes at UH Rainbow Babies and Children’s Hospital.
Articles by Jamie Wood, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Enlicitide for LDL-C Lowering in Adults With Hypercholesterolemia
2
What New 26-Week COMP006 Data Mean for TRD, With Boadie Dunlop, MD
3
Daily Inhaled TPIP Improved PAH Measures at 12 Months in OLE
4
FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD
5